These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 16105976)
1. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Appel S; Mirakaj V; Bringmann A; Weck MM; Grünebach F; Brossart P Blood; 2005 Dec; 106(12):3888-94. PubMed ID: 16105976 [TBL] [Abstract][Full Text] [Related]
2. Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone. Kock G; Bringmann A; Held SA; Daecke S; Heine A; Brossart P Blood; 2011 Mar; 117(13):3569-74. PubMed ID: 21296999 [TBL] [Abstract][Full Text] [Related]
3. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma). Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751 [TBL] [Abstract][Full Text] [Related]
4. PPAR-γ agonist pioglitazone regulates dendritic cells immunogenicity mediated by DC-SIGN via the MAPK and NF-κB pathways. Zhu W; Yan H; Li S; Nie W; Fan F; Zhu J Int Immunopharmacol; 2016 Dec; 41():24-34. PubMed ID: 27792919 [TBL] [Abstract][Full Text] [Related]
5. PPAR-gamma agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-kappaB pathways. Wei-guo Z; Hui Y; Shan L; Yun Z; Wen-cheng N; Fu-lin Y; Fang-yan F; Jun-hua G; Jian-hua Z Immunol Cell Biol; 2010; 88(3):305-12. PubMed ID: 19997078 [TBL] [Abstract][Full Text] [Related]
6. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. Tomita H; Osanai T; Toki T; Sasaki S; Maeda N; Murakami R; Magota K; Yasujima M; Okumura K Cardiovasc Res; 2005 Jul; 67(1):134-41. PubMed ID: 15949477 [TBL] [Abstract][Full Text] [Related]
7. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Marra F; Efsen E; Romanelli RG; Caligiuri A; Pastacaldi S; Batignani G; Bonacchi A; Caporale R; Laffi G; Pinzani M; Gentilini P Gastroenterology; 2000 Aug; 119(2):466-78. PubMed ID: 10930382 [TBL] [Abstract][Full Text] [Related]
8. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617 [TBL] [Abstract][Full Text] [Related]
9. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. Masamune A; Kikuta K; Satoh M; Sakai Y; Satoh A; Shimosegawa T J Biol Chem; 2002 Jan; 277(1):141-7. PubMed ID: 11606585 [TBL] [Abstract][Full Text] [Related]
10. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Lappas M; Permezel M; Rice GE Placenta; 2006; 27(11-12):1060-72. PubMed ID: 16434095 [TBL] [Abstract][Full Text] [Related]
11. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. Zingarelli B; Hake PW; Mangeshkar P; O'Connor M; Burroughs TJ; Piraino G; Denenberg A; Wong HR Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro. Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125 [TBL] [Abstract][Full Text] [Related]
13. 15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. Lin TH; Tang CH; Wu K; Fong YC; Yang RS; Fu WM J Cell Physiol; 2011 Dec; 226(12):3242-50. PubMed ID: 21344384 [TBL] [Abstract][Full Text] [Related]